高血糖症作为质母细胞瘤进展的驱动因素:从孟德尔随机化和单细胞转录组学的见解
Jin Li1, Wenjing Wu2, Liguo Ye3
1Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Brain research
|April 10, 2025
概括
高血糖水平和糖尿病可能会通过改变瘤微环境和激活GBM通路来增加质母细胞瘤 (GBM) 的风险. 这项研究使用遗传分析和小鼠模型来探索这种联系.
科学领域:
- 神经瘤学神经瘤学
- 代谢障碍 代谢障碍 代谢障碍
- 遗传学 遗传学 是一个
背景情况:
- 高血糖和糖尿病是影响质母细胞瘤 (GBM) 进展的潜在因素.
- 血糖水平和GBM之间的确切因果关系尚未完全阐明.
研究的目的:
- 调查高血糖和GBM风险之间的因果关系.
- 探索高血糖症对GBM瘤微环境和相关途径的影响.
主要方法:
- 孟德尔随机化 (MR) 分析使用来自英国生物银行和FinnGen.com的GWAS数据.
- 在高葡萄糖条件下的GBM小鼠模型中单细胞RNA测序.
- 基因组丰富分析 (GSEA) 基于糖尿病患者脑组织的转录组数据.
主要成果:
- 禁食血糖升高显示与增加的GBM风险有显著的遗传关联 (OR=40.991).
- 2型糖尿病 (T2D) 显示了与GBM的潜在因果关系 (ORs从2.100到2.740不等).
- 在小鼠模型中,高葡萄糖饮食增加了GBM干细胞和M2巨细胞;GSEA揭示了糖尿病人脑组织中的活性GBM通路.
结论:
- 高血糖症可能会积极促进GBM的进展.
- 提出的机制包括促进瘤微环境中的细胞变化和激活大脑组织中与GBM相关的途径.
更多相关视频
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
3.4K
05:45Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
9.6K
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Hypoglycemia and Glucagon
143
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
143
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
